Pluri Inc. (PLUR)

IL — Healthcare Sector
Peers: ANTX  QTTB  NXTC  IBIO  BOLD  PSTV  ITRM  INTS  SABS  JSPR 

Automate Your Wheel Strategy on PLUR

With Tiblio's Option Bot, you can configure your own wheel strategy including PLUR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PLUR
  • Rev/Share 0.1862
  • Book/Share 0.087
  • PB -4.1827
  • Debt/Equity -6.9707
  • CurrentRatio 4.8124
  • ROIC -0.6743

 

  • MktCap 24285976.0
  • FreeCF/Share -3.2802
  • PFCF -1.3333
  • PE -0.9034
  • Debt/Assets 0.8337
  • DivYield 0
  • ROE 4.684

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript
PLCKF, PLUR
Published: November 27, 2025 by: Seeking Alpha
Sentiment: Neutral

Plurilock Security Inc. ( PLUR:CA ) Q3 2025 Earnings Call November 27, 2025 11:00 AM EST Company Participants Ian Paterson - CEO & Director Scott Meyers - CFO & Corporate Secretary Conference Call Participants Ryan Freemantle Presentation Ryan Freemantle Good morning, and thank you for joining us for Plurilock Securities conference call to discuss its financial results for the quarter ending September 30, 2025. I'm Ryan Freemantle from Sophic Capital, and we handle Plurilock's Investor Relations.

Read More
image for news Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript
Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.
PLUR
Published: April 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

Acquisition of approximately 71% stake in Kokomodo Ltd. Acquisition uniquely combines Pluri's mass-scale cell production expertise with Kokomodo Ltd.

Read More
image for news Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.
Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution
PLUR
Published: February 19, 2025 by: GlobeNewsWire
Sentiment: Neutral

Food Industry Leader Teams With Ever After Foods to Accelerate Cultivated Meat Market Development Food Industry Leader Teams With Ever After Foods to Accelerate Cultivated Meat Market Development

Read More
image for news Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution

About Pluri Inc. (PLUR)

  • IPO Date 2003-06-30
  • Website https://pluri-biotech.com
  • Industry Biotechnology
  • CEO Yaacov Yanay
  • Employees 106
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.